三特异性抗体:从挑战到癌症治疗中的整合
Ahmed Reda Bahr1, Ibrahim Saleh Alawadi2, Laila Mohamed Akr1
1Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Critical reviews in oncology/hematology
|March 12, 2026
概括
三特异性抗体 (TsAbs) 在癌症免疫治疗中提供了一种强大的新方法,证明了其高疗效和克服治疗耐药性的潜力. 未来的发展旨在通过新的工程和组合疗法来提高它们的安全性和有效性.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 抗体工程 抗体工程
背景情况:
- 三特异性抗体 (TsAbs) 代表了癌症免疫疗法的重大进展.
- 它们以IgG类或非IgG类分子的形式存在,每个分子都有不同的结构性质.
研究的目的:
- 审查癌症治疗中的三种特异性抗体的工程,机制,疗效和挑战.
- 探索 TsAb 基疗法的未来方向和潜在改进.
主要方法:
- 使用了新的工程技术,如Knob-into-Hole (KiH),直角Fab和CrossMab等.
- TsAbs采用多种机制,包括T细胞和NK细胞参与,准多种瘤抗原,调节瘤微环境和药物结合.
主要成果:
- 临床前研究显示,TsAbs.的高疗效与中等安全性.
- 临床研究证实了强大的抗瘤作用,突出显示了其优势于单克隆和双特异性抗体以及CAR-T/TIL疗法.
- 挑战包括制造,免疫性和轻微的安全问题,正在探索像KiH工程这样的策略来减轻这些问题.
结论:
- 未来的 TsAb 开发可能包括四特异性抗体和与免疫检查点抑制剂的组合疗法.
- 进一步研究固体瘤,人工智能驱动的设计和预测生物标志物至关重要.
- 针对PI3K/AKT/mTOR和RTK-RAS等途径有望重塑癌症免疫疗法.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K


